Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms

被引:47
|
作者
Bhateja, Deepak Kumar [1 ]
Dhull, Dinesh K. [1 ]
Gill, Aneet [1 ]
Sidhu, Akramdeep [1 ]
Sharma, Saurabh [1 ]
Reddy, B. V. Krishna [1 ]
Padi, Satyanarayana S. V. [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India
关键词
Fenofibrate; Huntington's disease; MK886; 3-nitropropionic acid; Oxidative stress; NF-KAPPA-B; PPAR-ALPHA; OXIDATIVE STRESS; MICROGLIAL ACTIVATION; MITOCHONDRIAL TOXIN; HUNTINGTONS-DISEASE; STRIATAL DEGENERATION; EXPERIMENTAL-MODEL; SPINAL-CORD; CELL-DEATH;
D O I
10.1016/j.ejphar.2011.10.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators activated receptor is regarded as potential therapeutic targets to control various neurodegenerative disorders. However, none of the study has elucidated its effect in the treatment of Huntington's disease. We explored whether peroxisome proliferators activated receptor-a agonist may attenuate various behavioral and biochemical alterations induced by systemic administration of 3-nitropropionic acid (3-NP), an accepted experimental animal model of Huntington's disease phenotype. Intraperitoneal administration of 3-NP (20 mg/kg., i.p.) for 4 days in rats produced hypolocomotion, muscle incoordination, and cognitive dysfunction. Daily treatment with fenofibrate (100 or 200 mg/kg., p.o.), 30 min prior to 3-NP administration for a total of 4 days, significantly improved the 3-NP induced motor and cognitive impairment. Biochemical analysis revealed that systemic 3-NP administration significantly increased oxidative and nitrosative stress (increase lipid peroxidation, protein carbonyls and nitrite level), lactate dehydrogenase activity whereas, decreased the activities of catalase, superoxide dismutase, reduced glutathione, and succinate dehydrogenase. Fenofibrate treatment significantly attenuated oxidative damage, cytokines and improved mitochondrial complexes enzyme activity in brain. In the present study, MK886, a selective inhibitor of peroxisome proliferators activated receptor-a was employed to elucidate the beneficial effect through either receptor dependent or receptor independent neuroprotective mechanisms. Administration of MK886 (1 mg/kg, i.p.) prior to fenofibrate (200 mg/kg, p.o.) abolished the effect of fenofibrate. The results showed that receptor dependent neuroprotective effects of fenofibrate in 3-NP administered rats provide a new evidence for a role of PPAR-a activation in neuroprotection that is attributed by modulating oxidative stress and inflammation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 50 条
  • [21] The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
    Boor, Peter
    Celec, Peter
    Martin, Ina V.
    Villa, Luigi
    Hodosy, Julius
    Klenovicsova, Kristina
    Esposito, Ciro
    Schaefer, Stefan
    Albrecht-Kuepper, Barbara
    Ostendorf, Tammo
    Heidland, August
    Sebekova, Katarina
    KIDNEY INTERNATIONAL, 2011, 80 (11) : 1182 - 1197
  • [22] Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats
    Mirza, Roohi
    Sharma, Bhupesh
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2019, 76 : 6 - 16
  • [23] Effect of vitamin D on isoprenaline-induced myocardial infarction in rats: possible role of peroxisome proliferator-activated receptor-γ
    El-Gohary, Ola Ahmed
    Allam, Mona Maher
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 95 (06) : 641 - 646
  • [24] Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ
    Reddy, Raju C.
    Narala, Venkata R.
    Keshamouni, Venkateshwar G.
    Milam, Jami E.
    Newstead, Michael W.
    Standiford, Theodore J.
    BLOOD, 2008, 112 (10) : 4250 - 4258
  • [25] Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment
    Deplanque, D
    Gelé, P
    Pétrault, O
    Six, I
    Furman, C
    Bouly, M
    Nion, S
    Dupuis, B
    Leys, D
    Fruchart, JC
    Cecchelli, R
    Staels, B
    Duriez, P
    Bordet, R
    JOURNAL OF NEUROSCIENCE, 2003, 23 (15): : 6264 - 6271
  • [26] Activation of peroxisome proliferator-activated receptor-δ attenuates glutamate-induced neurotoxicity in HT22 mouse hippocampal cells
    Jin, Hana
    Ham, Sun Ah
    Kim, Min Young
    Woo, Im Sun
    Kang, Eun Sil
    Hwang, Jung Seok
    Lee, Ko-Woon
    Kim, Hye Jung
    Roh, Gu Seob
    Lim, Dae-Seog
    Kang, Dawon
    Seo, Han Geuk
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (08) : 1646 - 1653
  • [27] Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage
    Xu, Ruobing
    Wang, Shu
    Li, Weishan
    Liu, Zhen
    Tang, Jiaxin
    Tang, Xiaobo
    JOURNAL OF NEUROSURGERY, 2017, 127 (03) : 522 - 531
  • [28] Umbelliferone attenuates glycerol-induced myoglobinuric acute kidney injury through peroxisome proliferator-activated receptor-γ agonism in rats
    Kaur, Tajpreet
    Singh, Damanpreet
    Pathak, Devendra
    Singh, Amrit P.
    Singh, Balbir
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (11)
  • [29] Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats
    Kumar, Puneet
    Kalonia, Harikesh
    Kumar, Anil
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2009, 11 (05) : 439 - 450
  • [30] Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
    Maria Quintela, Ana
    Jimenez, Rosario
    Gomez-Guzman, Manuel
    Jose Zarzuelo, Maria
    Galindo, Pilar
    Sanchez, Manuel
    Vargas, Felix
    Cogolludo, Angel
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 730 - 741